Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MnCC Vaccine in Infants with DTP/Hib
NCT00314041Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 1997
- Primary completion
- Apr 1998
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 2, randomised, double-blind trial of Meningococcal group C polysaccharide conjugate vaccine in meningococcal meningitis (3 arms), sponsored by Pfizer. Primary endpoint: Antibody responses to MnCC and concomitant vaccines. Started Jun 1997; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00314041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314041.